A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
MVista® Blastomyces Antigen Quantitative EIA
Test Code15109
Alias/See Also
LAB00392
BLASTOMYCES ANTIGEN, QUANTITATIVE
BLASTOMYCES ANTIGEN, QUANTITATIVE
CPT Codes
87449
Preferred Specimen
2 mL random urine
Minimum Volume
0.5 mL urine, BAL or other body fluids • 0.8 mL CSF • 1.2 mL serum or plasma
Other Acceptable Specimens
Serum • Plasma collected in: Sodium heparin (green-top) tube, EDTA (lavender-top) tube or 3.2% sodium citrate (light blue-top) tube • BAL or CSF collected in a sterile screw-cap container
Instructions
Indicate specimen type and date drawn on test request form. Two unique patient identifiers required on specimen container. List all antifungal agents patient is receiving.
Ship to arrive Monday-Friday using a next day delivery service or 2nd day service. Do not ship by first class mail.
Note: Interfering substances and cross-reactivities include sodium hydroxide and sputolysin. Cross-reactivity occurs between blastomycosis and histoplasmosis and in paracoccidioidomycosis, penicillosis, coccidioidomycosis, aspergillosis and sporotrichosis.
Ship to arrive Monday-Friday using a next day delivery service or 2nd day service. Do not ship by first class mail.
Note: Interfering substances and cross-reactivities include sodium hydroxide and sputolysin. Cross-reactivity occurs between blastomycosis and histoplasmosis and in paracoccidioidomycosis, penicillosis, coccidioidomycosis, aspergillosis and sporotrichosis.
Transport Container
Plastic urine container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 14 days
Refrigerated: 14 days
Frozen: Indefinite
Refrigerated: 14 days
Frozen: Indefinite
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Samples in transport media, fixative or isolator tubes • Tissue • Biopsy • Sputum • Tracheal aspirate • FNA • Bone marrow aspirate • Bronchial brush • Stool
Methodology
Enzyme Immunoassay (EIA)
FDA Status
This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Setup Schedule
Mon-fri
Report Available
3-5 days
Reference Range
See Laboratory Report
Performing Laboratory
Mira Vista Diagnostics
4705 Decatur Blvd.
Indianapolis, IN 46241-9539